GlassScriptPhysician profile
Adison Weseloh
NPI 1477085850
$2,118.43
in general payments reported to CMS, 2019-2025
8 companies · $805 in 2025
The $805 reported for 2025 was more than what 85% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $429 · 2023: $419 · 2024: $466 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $983.07 | 2022-2024 | Senza |
| Medtronic, INC. | $390.27 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Globus Medical, INC. | $293.95 | 2025 | Senza |
| Boston Scientific Corporation | $225.96 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $144.32 | 2023 | |
| Stryker Corporation | $49.09 | 2025 | Spinejack, Mild Device Kit |
| Ambu INC. | $17.13 | 2025 | |
| Avanos Medical | $14.64 | 2025 | Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adison Weseloh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.